Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Recruiting · NCT05288790 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT | Blood-Borne Infections, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dysbiosis, Ear Diseases, Genital Diseases, HIV infectious disease, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Urogenital Diseases, cardiovascular disorder, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, microtia, otorhinolaryngologic disease, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 2 | 2026-08-27 | NCT05288790 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boston University | 96 |
| University of Louisville | 62 |
| Vanderbilt University Medical Center | 299 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | United States | 427 |